GRDX GridAI Technologies Corp.

BEARISH Impact: 7/10 8-K
Horizon days Filed May 14, 2026 Processed 26d 21h ago SEC 0001104659-26-061136
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Latest settled — T+5d
GRDX ▲ +25.06% at T+5d
SHORT call ✗ call lost -25.06% · α vs SPY -24.10% · entry $3.87 → $4.84
Next anchor: T+20d tomorrow
Currently $5.80 · -49.74% from $3.87 entry (call sign-flipped)
Entry anchored
May 14, 03:58 PM ET
via Databento tick
T+1d
-2.33%
call +2.33% · α +2.26%
$3.78
settled 26d ago
T+5d
+25.06%
call -25.06% · α -24.10%
$4.84
settled 20d ago
T+20d
call — · α —
tomorrow
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

GridAI Technologies Corp. entered into two securities purchase agreements to raise a combined total of approximately $7.79 million ($5.25M + $2.54M) through the sale of common stock, pre-funded warrants, and common warrants in a private placement. The proceeds are earmarked for general corporate purposes, including potential acquisitions and debt repayment. The substantial dilution—roughly 37% of the current $21M market cap—combined with the company's weak analyst consensus (0% bullish) and a prior short report that lost -8% at T+5, makes this a clearly bearish capital raise for existing shareholders.

Key Financial Metrics

Offering Size
$7.8M

Actionable Insight

Expect significant downward pressure on GRDX as the market prices in ~37% dilution. The registration rights agreement will allow investors to resell shares, adding overhang. Monitor for the 8-K filing and subsequent resale registration statement effectiveness. Short sellers may target this name given the dilutive structure and weak fundamentals.

Key Facts

  • GridAI entered into two Securities Purchase Agreements to raise approximately $5,250,000 and $2,540,000, totaling ~$7.79 million.
  • The offering includes common stock, pre-funded warrants, and common warrants exercisable for 100% of the shares purchased.
  • Proceeds are for general corporate purposes, including potential acquisitions and debt repayment.
  • The company has a $21M market cap, making this a ~37% dilutive event relative to current market value.
  • Analyst consensus is heavily bearish: 0 Strong Buy, 3 Hold, 1 Sell, 2 Strong Sell (0% bullish).
  • A prior short report on GRDX lost -8% at T+5, indicating the stock has been under pressure.

Financial Impact

Total offering of approximately $7.79 million represents roughly 37% of the $21 million market cap, causing significant dilution.

dilutionmarket capshare count

Risk Factors

  • Massive dilution of ~37% relative to current market cap will pressure the stock price.
  • Weak analyst sentiment (0% bullish) suggests limited institutional support.
  • Proceeds used for general corporate purposes, not a specific value-creating catalyst.
  • Warrant overhang (100% of shares sold) adds future dilution risk.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-061136
Document: tm2614570d1_ex10-1.htm0001104659-26-061136
Document: tm2614570d1_ex10-2.htm0001104659-26-061136
2 reports for GRDX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for GRDX — sortable, filterable
Type Now
May 14, 2026
26d ago
8-K
BEARISH ★ 7/10
$3.87 $4.84▼ −25.06%▼ −24.10%$5.80 (−49.74%)
Apr 24, 2026
6w ago
8-K
BEARISH ★ 7/10
$2.25 $2.43▼ −8.00%▼ −7.60%$5.80 (−157.56%)
Showing 2 of 2

US Market Status

Market Open — Closes in 2h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access